Safety of Toremifene and Tamoxifen Therapy in Premenopausal Patients With Operable Breast Cancer: A Randomized, Controlled, Prospective, Observational Study

Trial Profile

Safety of Toremifene and Tamoxifen Therapy in Premenopausal Patients With Operable Breast Cancer: A Randomized, Controlled, Prospective, Observational Study

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 27 Sep 2017

At a glance

  • Drugs Toremifene (Primary) ; Tamoxifen
  • Indications Breast cancer
  • Focus Adverse reactions
  • Acronyms TTOS
  • Most Recent Events

    • 20 Sep 2017 Planned End Date changed from 1 Jun 2018 to 1 Aug 2018.
    • 20 Sep 2017 Planned primary completion date changed from 1 Dec 2017 to 1 Aug 2018.
    • 20 Sep 2017 Status changed from recruiting to active, no longer recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top